RVTY
stock Healthcare Diagnostics & ResearchOverall Mixed · 50%
- Fundamentals Weak
- Trajectory Steady
- Leadership Stable
A read across fundamentals, recent price & growth trajectory, and leadership stability. For fun and reading at a glance, not investment advice.
What the indicators say
Mixed 4 of 5 trend signals bullishRSI 60 — firm momentum, not yet overbought.
A mechanical reading of the chart’s indicators — not investment advice.
Key statsas of Jun 3
- Open
- $101.07
- +0.68%
- Close
- $101.07
- +0.68%
- Current
- $101.07
- Prev close
- $100.39
- Today
- 1.13M
- 3-mo avg
- 1.27M
Earningscalendar synced from Yahoo 57d ago
- Most recent
- May 577 days ago
- Next expected
- Jul 27in 6 days
Recent earnings dates
- May 5 77 days ago
- Feb 2 169 days ago
- Jan 13 189 days ago
- Oct 27, 2025 267 days ago
Past earnings dates come from RVTY’s 8-K item 2.02 filings; the next date is Yahoo’s when available, otherwise estimated from the recent reporting cadence.
Fundamentalssynced from SEC 51d ago
Across the nine graded ratios (FY2025 balance-sheet figures, P/E on TTM through Apr 2026 earnings, against the latest price), RVTY’s fundamentals read as weak overall.
At 48.6x, the price is steep relative to profit; the stock leans heavily on growth that has yet to arrive.
Share price divided by earnings per share: what you pay for each $1 of yearly profit. Roughly 15 to 25 is typical, above 40 is richly priced, and negative means the company is losing money.
A 0.3% yield is modest: a small income on top of whatever the share price does.
The yearly dividend as a percent of the share price: the cash income each share pays out. Around 2 to 6% is healthy; above roughly 8% often signals the payout may be cut.
A 8.4% margin is solid, in the ordinary range for a profitable company.
The share of revenue left as profit once every cost is paid. Above 15% is strong; below 5% leaves little cushion against a bad year.
A 3.3% return on equity is weak; owners' capital is barely being put to work.
Profit earned on each dollar of shareholder equity: how well the company compounds its owners' capital. Above 15% is strong.
A 2.0% return on assets is low; the asset base is generating little profit.
Profit earned on each dollar of assets: how efficiently the whole asset base is used. Above 8% is strong.
At 0.68, the company carries less in liabilities than in equity, a conservative balance sheet.
Total liabilities divided by shareholder equity: how heavily the company leans on borrowing. Below 1 is conservative; above 2 is highly leveraged.
At 1.68, short-term assets comfortably cover short-term bills.
Current assets divided by current liabilities: whether short-term resources cover short-term bills. Above 1.5 is comfortable; below 1 is tight.
Revenue grew 3.7% from the prior year: steady, modest expansion.
Change in annual revenue from the prior fiscal year: whether the top line is expanding. Above 10% is strong growth; below 0 means revenue is shrinking.
Net income fell 10.8% from the prior year; profit is shrinking.
Change in annual net income from the prior fiscal year: whether profit is expanding. Above 10% is strong; below 0 means profit is falling.
Financialssynced from SEC 51d ago
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|
| Revenue | $2.7B | $3.8B | $2.8B | $2.8B | $2.9B |
| Net income | $727.9M | $943.2M | $693.1M | $270.4M | $241.2M |
| Diluted EPS | $6.49 | $8.08 | $5.55 | $2.20 | $2.07 |
| Dividend / share | $0.28 | — | $0.28 | $0.28 | $0.28 |
| Total assets | $8.0B | $15.0B | $13.6B | $12.4B | $12.2B |
| Total liabilities | $4.2B | $7.9B | $5.7B | $4.7B | $4.9B |
| Shareholder equity | $3.7B | $7.1B | $7.4B | $7.7B | $7.3B |
| Q2-2024 | Q3-2024 | Q4-2024 | Q1-2025 | Q2-2025 | Q3-2025 | Q4-2025 | Q1-2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $691.7M | $684.0M | $729.4M | $664.8M | $720.3M | $698.9M | $772.1M | $711.1M |
| Net income | $26.0M | $26.0M | $192.3M | $42.2M | $42.2M | $42.2M | $114.5M | $40.7M |
| Diluted EPS | $0.45 | $0.77 | $0.77 | $0.35 | $0.46 | $0.40 | $0.86 | $0.36 |
| Dividend / share | $0.07 | $0.07 | $0.07 | $0.07 | $0.07 | $0.07 | $0.07 | $0.07 |
Leadershipsynced from SEC 53d ago
- Gonzales Anita Vice President and CAO
- Barrett Peter Director
- Chapin Samuel R. Director
- Klobuchar Michael A Director
- Mcmurry-Heath Michelle Director
- Michas Alexis P Director
- Vandebroek Sophie V. Director
- Vounatsos Michel Director
- Witney Frank Director
- Witz Pascale Director
Officers and board are drawn from RVTY’s recent SEC ownership filings (Forms 3, 4 and 5).
Recent leadership changes
Notable recent eventspast year
- May 6 +7.4% one-day move
- May 5 +6.7% one-day move
- Apr 30 +5.3% one-day move
- Apr 29 New 6-month low (-30% off peak)
- Apr 23 −7.6% one-day move
- Mar 12 −5.4% one-day move
- Mar 6 −5.4% one-day move
- Feb 12 −5.5% one-day move
- Feb 3 −5.6% one-day move
- Jan 13 +6.0% one-day move
- Oct 24, 2025 Officer or director change reported in an 8-K
- Sep 3, 2025 −5.1% one-day move
- Jul 31, 2025 New 6-month low (-31% off peak)
- Jul 28, 2025 −8.3% one-day move
- Jul 22, 2025 +6.0% one-day move
Large daily moves, new 6-month lows, year-over-year fundamentals swings, and reported leadership changes — pulled from the data this app already holds, never investment advice.
Dividendssynced from Yahoo 52d ago
- 2025 total
- $0.28
- 2026 so far
- $0.142 payments
- 2026 projected
- $0.28+0.0% vs 2025
Projection scales RVTY’s declared payments so far this year up to the inferred cadence, then compares to last year’s total. Between payouts it is an estimate, not a guarantee.
Payment history
- Apr 17 $0.07
- Jan 16 $0.07
- Oct 17, 2025 $0.07
- Jul 18, 2025 $0.07
- Apr 17, 2025 $0.07
- Jan 17, 2025 $0.07
- Oct 18, 2024 $0.07
- Jul 19, 2024 $0.07
- Apr 18, 2024 $0.07
- Jan 18, 2024 $0.07
- Oct 19, 2023 $0.07
- Jul 20, 2023 $0.07
- Apr 20, 2023 $0.07
- Jan 19, 2023 $0.07
- Oct 20, 2022 $0.07
- Jul 21, 2022 $0.07
- Apr 21, 2022 $0.07
- Jan 20, 2022 $0.07
- Oct 21, 2021 $0.07
- Jul 15, 2021 $0.07
Recent SEC filingssynced from SEC 51d ago
- 10-Q Quarterly report
- 8-K Current report
- 8-K Current report
- DEF 14A Proxy statement
- 10-K Annual report
- 8-K Current report
- 8-K Current report
- 10-Q Quarterly report
- 8-K Current report
- 8-K Current report
- 10-Q Quarterly report
- 8-K Current report
- 10-Q Quarterly report
- 8-K Current report
- 8-K Current report
- DEF 14A Proxy statement
- 10-K Annual report
- 8-K Current report